The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants
Open accessAbstract
BACKGROUND: Bronchopulmonary dysplasia remains a major problem in neonatal intensive care units. Persistent inflammation in the lungs is the most likely underlying pathogenesis. Corticosteroids have been used to prevent or treat bronchopulmonary dysplasia because of their potent anti-inflammatory effects. OBJECTIVES: To examine the relative benefits and adverse effects of systemic postnatal corticosteroids commenced within the first seven days of life for preterm infants at risk of developing bronchopulmonary dysplasia. SEARCH METHODS: For the 2017 update, we used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 1); MEDLINE via PubMed (January 2013 to 21 February 2017); Embase (January 2013 to 21 February 2017); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) (January 2013 to 21 February 2017). We also searched clinical trials databases, conference proceedings, and reference lists of retrieved articles for randomised controlled trials (RCTs) and quasi-randomised trials. SELECTION CRITERIA: For this review, we selected RCTs examining systemic postnatal corticosteroid treatment within the first seven days of life (early) in high-risk preterm infants. Most studies evaluated the use of dexamethasone, but we also included studies that assessed hydrocortisone, even when used primarily for management of hypotension. DATA COLLECTION AND ANALYSIS: We used the GRADE approach to assess the quality of evidence.We extracted and analysed data regarding clinical outcomes that included mortality, bronchopulmonary dysplasia, death or bronchopulmonary dysplasia, failure to extubate, complications during primary hospitalisation, and long-term health outcomes. MAIN RESULTS: We included 32 RCTs enrolling a total of 4395 participants. The overall risk of bias of included studies was probably low, as all were RCTs, and most trials used rigorous methods. Investigators reported significant benefits for the following outcomes overall: lower rates of failure to extubate, decreased risks of bronchopulmonary dysplasia both at 28 days of life and at 36 weeks' postmenstrual age, death or bronchopulmonary dysplasia at 28 days of life and at 36 weeks' postmenstrual age, patent ductus arteriosus, and retinopathy of prematurity (ROP), including severe ROP. Researchers found no significant differences in rates of neonatal or subsequent mortality; they noted that gastrointestinal bleeding and intestinal perforation were important adverse effects, and that risks of hyperglycaemia, hypertension, hypertrophic cardiomyopathy, and growth failure were increased. The 13 trials that reported late outcomes described several adverse neurological effects at follow-up examination, including cerebral palsy. However, study authors indicated that major neurosensory disability was not significantly increased, either overall in the eight studies for which this outcome could be determined, or in the two individual studies in which rates of cerebral palsy or abnormal neurological examination were significantly increased. Moreover, data show that rates of the combined outcomes of death or cerebral palsy, or of death or major neurosensory disability, were not significantly increased. Two-thirds of studies used dexamethasone (n = 21). Subgroup analyses by type of corticosteroid revealed that most of the beneficial and harmful effects of treatment were attributable to dexamethasone. However, as with dexamethasone, hydrocortisone was associated with reduced rates of patent ductus arteriosus, mortality, and the combined outcome of mortality or chronic lung disease, but with increased occurrence of intestinal perforation. Results showed that hydrocortisone was not associated with obvious longer-term problems.Use of the GRADE approach revealed that the quality of evidence was high for the major outcomes considered, but review authors downgraded quality one level for several outcomes (mortality at latest age, bronchopulmonary dysplasia at 36 weeks, and death or bronchopulmonary dysplasia at 36 weeks) because of weak evidence of publication bias or moderate heterogeneity (death or cerebral palsy). AUTHORS' CONCLUSIONS: Benefits of early postnatal corticosteroid treatment (≤ 7 days), particularly dexamethasone, may not outweigh adverse effects associated with this treatment. Although early corticosteroid treatment facilitates extubation and reduces risk of bronchopulmonary dysplasia and patent ductus arteriosus, it causes short-term adverse effects including gastrointestinal bleeding, intestinal perforation, hyperglycaemia, hypertension, hypertrophic cardiomyopathy, and growth failure. Long-term follow-up studies report increased risk of abnormal findings on neurological examination and increased risk of cerebral palsy. However, the methodological quality of studies examining long-term outcomes is limited in some cases: Surviving children have been assessed predomi
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Northway, W. H., Rosan, R. C., & Porter, D. Y. (1967) · New England Journal of Medicine · doi:10.1056/nejm196702162760701 · Cited by 3,013
Caffeine Therapy for Apnea of Prematurity
Schmidt, B., Roberts, R. S., Davis, P., Doyle, L. W., Barrington, K. J., Ohlsson, A., Solimano, A., & Tin, W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054065 · Cited by 1,208
Self-citationOutcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of Prematurity
Yeh, T. F., Lin, Y. J., Lin, H. C., Huang, C. C., Hsieh, W. S., Lin, C. H., & Tsai, C. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032089 · Cited by 596
A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary Dysplasia
Cummings, J. J., D'Eugenio, D. B., & Gross, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906083202301 · Cited by 483
Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants
Stark, A. R., Carlo, W. A., Tyson, J. E., Papile, L.-A., Wright, L. L., Shankaran, S., Donovan, E. F., Oh, W., Bauer, C. R., Saha, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440203 · Cited by 479
Self-citationWatterberg, K. L., Gerdes, J. S., Cole, C. H., Aucott, S. W., Thilo, E. H., Mammel, M. C., Couser, R. J., Garland, J. S., Rozycki, H. J., Leach, C. L., et al. (2004) · Pediatrics · doi:10.1542/peds.2004-1159 · Cited by 432
Early Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Yeh, T. F., Lin, Y. J., Huang, C. C., Chen, Y. J., Lin, C. H., Lin, H. C., Hsieh, W. S., & Lien, Y. J. (1998) · Pediatrics · doi:10.1542/peds.101.5.e7 · Cited by 418
Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
Baud, O., Foix-L'Helias, L., Kaminski, M., Audibert, F., Jarreau, P.-H., Papiernik, E., Huon, C., Lepercq, J., Dehan, M., & Lacaze-Masmonteil, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411604 · Cited by 414
Controlled Trial of Dexamethasone in Respirator-Dependent Infants with Bronchopulmonary Dysplasia
Avery, G. B., Fletcher, A. B., Kaplan, M., & Brudno, D. S. (1985) · Pediatrics · doi:10.1542/peds.75.1.106 · Cited by 379
O'Shea, T. M., Kothadia, J. M., Klinepeter, K. L., Goldstein, D. J., Jackson, B. G., Weaver, R. G., & Dillard, I. A. R. G. (1999) · Pediatrics · doi:10.1542/peds.104.1.15 · Cited by 376
Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
Shinwell, E. S., Karplus, M., Reich, D., Weintraub, Z., Blazer, S., Bader, D., Yurman, S., Dolfin, T., Kogan, A., Dollberg, S., et al. (2000) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.83.3.f177 · Cited by 368
Baud, O., Maury, L., Lebail, F., Ramful, D., El Moussawi, F., Nicaise, C., Zupan-Simunek, V., Coursol, A., Beuchée, A., Bolot, P., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00202-6 · Cited by 364
Bayley Scales of Infant Development
(2005) · Encyclopedia of Human Development · doi:10.4135/9781412952484.n81 · Cited by 321
CONTROLLED TRIAL OF DEXAMETHASONE THERAPY IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
Mammel, M., Johnson, D., Green, T., & Thompson, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92139-6 · Cited by 307
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H., Ehrenkranz, R., & Doyle, L. (2003) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146 · Cited by 303
Self-citationEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub2 · Cited by 298
Self-citationHalliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001144 · Cited by 271
Self-citationProphylaxis Against Early Adrenal Insufficiency to Prevent Chronic Lung Disease in Premature Infants
Watterberg, K. L., Gerdes, J. S., Gifford, K. L., & Lin, H.-M. (1999) · Pediatrics · doi:10.1542/peds.104.6.1258 · Cited by 256
Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants
Halliday, H., Ehrenkranz, R., & Doyle, L. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001145 · Cited by 218
Self-citationNg, P. C., Lee, C. H., Bnur, F. L., Chan, I. H. S., Lee, A. W. Y., Wong, E., Chan, H. B., Lam, C. W. K., Lee, B. S. C., & Fok, T. F. (2006) · Pediatrics · doi:10.1542/peds.2005-0869 · Cited by 217
Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001145.pub2 · Cited by 205
Self-citationHalac, E., Halac, J., Bégué, E. F., Casañas, J. M., Indiveri, D. R., Petit, J. F., Figueroa, M. J., Olmas, J. M., Rodriíguez, L. A., Obregón, R. J., et al. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)72461-6 · Cited by 191
Shah, V. S., Ohlsson, A., Halliday, H. L., & Dunn, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001969.pub4 · Cited by 185
Self-citationYeh, T. F., Lin, Y. J., Hsieh, W. S., Lin, H. C., Lin, C. H., Chen, J. Y., Kao, H. A., & Chien, C. H. (1997) · Pediatrics · doi:10.1542/peds.100.4.e3 · Cited by 184
Influence of Postnatally Administered Glucocorticoids on Rat Lung Growth
Tschanz, S. A., Damke, B. M., & Burri, P. H. (1995) · Neonatology · doi:10.1159/000244241 · Cited by 184
A CONTROLLED TRIAL OF HYDROCORTISONE THERAPY IN INFANTS WITH RESPIRATORY DISTRESS SYNDROME
Baden, M., Bauer, C. R., Colle, E., Klein, G., Taeusch, H. W., & Stern, L. (1972) · Pediatrics · doi:10.1542/peds.50.4.526 · Cited by 179
A Multicenter Trial of Two Dexamethasone Regimens in Ventilator-Dependent Premature Infants
Papile, L.-A., Tyson, J. E., Stoll, B. J., Wright, L. L., Donovan, E. F., Bauer, C. R., Krause-Steinrauf, H., Verter, J., Korones, S. B., Lemons, J. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381604 · Cited by 172
Self-citationInflammatory mediators and bronchopulmonary dysplasia.
Groneck, P., & Speer, C. P. (1995) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.73.1.f1 · Cited by 171
Watterberg, K. L., Shaffer, M. L., Mishefske, M. J., Leach, C. L., Mammel, M. C., Couser, R. J., Abbasi, S., Cole, C. H., Aucott, S. W., Thilo, E. H., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-3158 · Cited by 162
Bhuta, T., & Ohlsson, A. (1998) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.79.1.f26 · Cited by 145
Groneck, P., Reuss, D., Götze‐Speer, B., & Speer, C. P. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(09)90024-5 · Cited by 145
Peltoniemi, O. M., Kari, M. A., Heinonen, K., Saarela, T., Nikolajev, K., Andersson, S., Voutilainen, R., & Hallman, M. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.040 · Cited by 141
Baud, O., Trousson, C., Biran, V., Leroy, É., Mohamed, D., Alberti, C., & for the PREMILOC Trial Group (2017) · JAMA · doi:10.1001/jama.2017.2692 · Cited by 140
Yöder, M. C., Chua, R., & Tepper, R. S. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.5_pt_1.1044 · Cited by 137
Shaffer, M. L., Baud, O., Lacaze‐Masmonteil, T., Peltoniemi, O. M., Bonsante, F., & Watterberg, K. L. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.10.004 · Cited by 131
Dexamethasone Therapy Increases Infection in Very Low Birth Weight Infants
Stoll, B. J., Temprosa, M. G., Tyson, J. E., Papile, L. A., Wright, L. L., Bauer, C. R., Donovan, E. F., Korones, S. B., Lemons, J. A., Fanaroff, A. A., et al. (1999) · PEDIATRICS · doi:10.1542/peds.104.5.e63 · Cited by 123
Self-citationBrozanski, B. S., Jones, J., Gilmour, C., Balsan, M. J., Vazquez, R. L., Israel, B. A., Newman, B., Mimouni, F. B., & Guthrie, R. D. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70410-8 · Cited by 121
Weichsel, M. E. (1977) · Annals of Neurology · doi:10.1002/ana.410020503 · Cited by 120
Sequelae of Early Steroid Administration to the Newborn Infant
Fitzhardinge, P. M., Eisen, A. H., Lejtenyi, C., Metrakos, K., & Ramsay, M. (1974) · PEDIATRICS · doi:10.1542/peds.53.6.877 · Cited by 118
Kazzi, N. J., Brans, Y. W., & Poland, R. L. (1990) · PEDIATRICS · doi:10.1542/peds.86.5.722 · Cited by 116
Ohlsson, A., Calvert, S., Hosking, M., et al. (1992) · Acta Paediatrica · doi:10.1111/j.1651-2227.1992.tb12096.x · Cited by 110
Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response
Flagel, S. B., Vázquez, D. M., Watson, S. J., & Neal, C. R. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2002.282.1.r55 · Cited by 110
Efird, M. M., Heerens, A. T., Gordon, P. V., Bose, C. L., & Young, D. A. (2004) · Journal of Perinatology · doi:10.1038/sj.jp.7211193 · Cited by 108
Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants
Onland, W., Jaegere, A. P. D., Offringa, M., & van Kaam, A. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010941.pub2 · Cited by 105
Clinical Trials of Postnatal Corticosteroids: Inhaled and Systemic
Halliday, H. L. (1999) · Neonatology · doi:10.1159/000047044 · Cited by 104
Self-citationEffect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia
van Goudoever, J. B., Wattimena, J. L. D., Carnielli, V. P., Sulkers, E., DEGENHART, H. J., & Sauer, P. J. J. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70265-9 · Cited by 101
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants
Doyle, L. W., Ehrenkranz, R. A., & Halliday, H. L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001145.pub3 · Cited by 100
Self-citationDoyle, L. W., Ehrenkranz, R. A., & Halliday, H. L. (2010) · Neonatology · doi:10.1159/000286212 · Cited by 99
Self-citationEarly Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease
The Vermont Oxford Network Steroid Study Group (2001) · PEDIATRICS · doi:10.1542/peds.108.3.741 · Cited by 99
Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease
Soll, R. F. (1999) · Pediatric Research · doi:10.1203/00006450-199904020-01345 · Cited by 91
Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
Kari, M. A., Heinonen, K., Ikonen, R., Koivisto, M., & Raivio, K. O. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.5_spec_no.566 · Cited by 89
Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications
Noble-Jamieson, C. M., Regev, R. H., & Silverman, M. E. (1989) · European Journal of Pediatrics · doi:10.1007/bf00444135 · Cited by 80
Tapia, J. L., Ramírez‐Campillo, R., Cifuentes, J. A. B., Fabres, J. G., Hübner, M. E., Bancalari, A., Mercado, M. E., Standen, J., & Escobar, M. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70483-4 · Cited by 76
Durand, M., Mendoza, M. E., Tantivit, P., Kugelman, A., & McEvoy, C. T. (2002) · PEDIATRICS · doi:10.1542/peds.109.2.262 · Cited by 73
Wilson, D. M., Baldwin, R. B., & Ariagno, R. L. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80398-6 · Cited by 72
Doyle, L. W., & Davis, P. G. (2000) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.2000.00481.x · Cited by 69
Self-citationEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants
Halliday, H. L., Ehrenkranz, R. A., & Doyle, L. W. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001146.pub3 · Cited by 66
Self-citationBloomfield, F. H., Knight, D. B., & Harding, J. E. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70277-x · Cited by 64
O’Shea, T. M., Washburn, L. K., Nixon, P. A., & Goldstein, D. J. (2007) · PEDIATRICS · doi:10.1542/peds.2007-0486 · Cited by 63
The Influence of Betamethasone and Dexamethasone on Motor Development in Young Rats
Gramsbergen, A., & Mulder, E. J. H. (1998) · Pediatric Research · doi:10.1203/00006450-199807000-00017 · Cited by 56
D’Angio, C. T., Maniscalco, W. M., Ryan, R. M., Avissar, N. E., Basavegowda, K. P., & Sinkin, R. A. (1999) · Neonatology · doi:10.1159/000014168 · Cited by 54
Nixon, P. A., Washburn, L. K., Schechter, M. S., & O’Shea, T. M. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.12.013 · Cited by 53
Romagnoli, C., Zecca, E., Vento, G., Carolis, M. P. D., Papacci, P., & Tortorolo, G. (1999) · Intensive Care Medicine · doi:10.1007/s001340050935 · Cited by 48
Walther, F. J., Findlay, R. D., & Durand, M. (2003) · Early Human Development · doi:10.1016/s0378-3782(03)00082-3 · Cited by 42
More trials on early treatment with corticosteroids are needed
Subhedar, N. V., Bennett, A. J., Wardle, S. P., & Shaw, N. J. (2000) · BMJ · doi:10.1136/bmj.320.7239.941 · Cited by 33
Effect of Dexamethasone Therapy on the Neonatal Ductus Arteriosus
Morales, P., Rastogi, A., Bez, M. L., Akintorin, S. M., Pyati, S., Andes, S., & Pildes, R. S. (1998) · Pediatric Cardiology · doi:10.1007/s002469900290 · Cited by 31
Washburn, L. K., Nixon, P. A., & O’Shea, T. M. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0973 · Cited by 25
Surfactant phosphatidylcholine composition during dexamethasone treatment in chronic lung disease
Ashton, M. R., Postle, A. D., Smith, D. E., et al. (1994) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.71.2.f114 · Cited by 19
Cited by
European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update
Sweet, D. G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., Simeoni, U., et al. (2019) · Neonatology · doi:10.1159/000499361 · Cited by 1,613
Self-citationEuropean Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update
Sweet, D. G., Carnielli, V. P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., Ozek, E., te Pas, A., Plavka, R., Roehr, C. C., Saugstad, O. D., et al. (2023) · Neonatology · doi:10.1159/000528914 · Cited by 704
Self-citationDiagnosis and management of bronchopulmonary dysplasia
Gilfillan, M., Bhandari, A., & Bhandari, V. (2021) · BMJ · doi:10.1136/bmj.n1974 · Cited by 311
Preoperative cardiopulmonary evaluation in specific neonatal surgery
Petroze, R. T., & Puligandla, P. S. (2019) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2019.01.002 · Cited by 17
Metadata
- Authors
- Doyle, L. W., Cheong, J. L., Ehrenkranz, R. A., & Halliday, H. L.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-10-24
- Volume
- 2018
- Issue
- 1
- Pages
- CD001145-CD001145
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2765280053
- Cited by
- 260
- References
- 68
- FWCI
- 18.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.